2 more succumb to COVID-19 in Tuguegarao City | Inquirer News

2 more succumb to COVID-19 in Tuguegarao City

By: - Correspondent / @VillVisayaJrINQ
/ 01:55 PM January 16, 2021

Photo by Don Lejano/INQUIRER.net

TUGUEGARAO CITY – A middle-aged detainee and a senior citizen succumbed to the coronavirus disease 2019 (COVID-19)  on the same day that 17 new infections were recorded in this city on Friday (Jan. 15).

As of Saturday,  Tuguegarao City has logged 14 COVID-19 deaths, according the Cagayan Provincial Health Office said.

Article continues after this advertisement

The 55-year-old detainee at the Don Domingo police precinct was also hypertensive and diabetic.

FEATURED STORIES

The second fatality, a 64-year-old man was initially treated after complaining of mild colds.

He was also suffering from chronic kidney disease, hypertension and gout.

Article continues after this advertisement

Tuguegarao City  currently has 159 active COVID-19 cases, while the entire province of Cagayan has 289 active cases.

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Cagayan, COVID-19

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.